Use of amifostine in hematologic malignancies, myelodysplastic syndrome, and acute leukemia

被引：0
作者：
List, AF [1 ]
机构：
[1] Univ Arizona, Arizona Canc Ctr, Bone Marrow Transplant Program, Tucson, AZ 85724 USA
来源：
SEMINARS IN ONCOLOGY | 1999年 / 26卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：61 / 65
页数：5
相关论文
共 30 条
[1]  
CALABROJONES PM, 1988, CANCER RES, V48, P3634
[2]  
DECASTRO CM, 1997, BLOOD S, V80, pA4034
[3]  
DOUAY L, 1995, BLOOD, V86, P2849
[4]  
ELGHISSASSI F, 1997, P AN M AM SOC CLIN, V16, P1958
[5]   WR-2721 PROTECTS AGAINST THE HEMATOLOGIC TOXICITY OF CYCLOPHOSPHAMIDE - A CONTROLLED PHASE-II TRIAL [J].
GLOVER, D ;
GLICK, JH ;
WEILER, C ;
HUROWITZ, S ;
KLIGERMAN, MM .
JOURNAL OF CLINICAL ONCOLOGY, 1986, 4 (04) :584-588
[6]   INHIBITION OF TOPOISOMERASE II-ALPHA ACTIVITY IN CHO K1 CELLS BY 2-[(AMINOPROPYL)AMINO]ETHANETHIOL (WR-1065) [J].
GRDINA, DJ ;
CONSTANTINOU, A ;
SHIGEMATSU, N ;
MURLEY, JS .
RADIATION RESEARCH, 1994, 138 (01) :44-52
[7]   CHEMICAL PROTECTION AND CELL-CYCLE EFFECTS ON RADIATION-INDUCED MUTAGENESIS [J].
GRDINA, DJ ;
SIGDESTAD, CP .
CELL PROLIFERATION, 1992, 25 (01) :23-29
[8]   RADIATION PROTECTORS - THE UNEXPECTED BENEFITS [J].
GRDINA, DJ ;
SIGDESTAD, CP .
DRUG METABOLISM REVIEWS, 1989, 20 (01) :13-42
[9]   Erythropoietin-induced activation of STAT5 is impaired in the myelodysplastic syndrome [J].
Hoefsloot, LH ;
vanAmelsvoort, MP ;
Breeders, LCAM ;
vanderPlas, DC ;
vanLom, K ;
Hoogerbrugge, H ;
Touw, IP ;
Lowenberg, B .
BLOOD, 1997, 89 (05) :1690-1700
[10]   ENHANCEMENT OF TOPOISOMERASE I-MEDIATED UNWINDING OF SUPERCOILED DNA BY THE RADIOPROTECTOR WR-33278 [J].
HOLWITT, EA ;
KODA, E ;
SWENBERG, CE .
RADIATION RESEARCH, 1990, 124 (01) :107-109
123